» Articles » PMID: 27412684

Neurological Complications of Ebola Virus Infection

Overview
Specialty Neurology
Date 2016 Jul 15
PMID 27412684
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Ebola virus disease is one of the deadliest pathogens known to man, with a mortality rate between 25-90% depending on the species and outbreak of Ebola. Typically, it presents with fever, headache, voluminous vomiting and diarrhea, and can progress to a hemorrhagic illness; neurologic symptoms, including meningoencephalitis, seizures, and coma, can also occur. Recently, an outbreak occurred in West Africa, affecting > 28,000 people, and killing > 11,000. Owing to the magnitude of this outbreak, and the large number (>17,000) of Ebola survivors, the medical and scientific communities are learning much more about the acute manifestations and sequelae of Ebola. A number of neurologic complications can occur after Ebola, such as seizures, memory loss, headaches, cranial nerve abnormalities, and tremor. Ebola may also persist in some immunologically privileged sites, including the central nervous system, and can rarely lead to relapse in disease. Owing to these findings, it is important that survivors are evaluated and monitored for neurologic symptoms. Much is unknown about this disease, and treatment remains largely supportive; however, with ongoing clinical and basic science, the mechanisms of how Ebola affects the central nervous system and how it persists after acute disease will hopefully become more clear, and better treatments and clinical practices for Ebola patients will be developed.

Citing Articles

Modular Polymerase Synthesis and Internal Protein Domain Swapping via Dual Opposed Frameshifts in the Ebola Virus L Gene.

Stubbs D, Ruzicka J, Taylor E Pathogens. 2024; 13(10).

PMID: 39452701 PMC: 11510084. DOI: 10.3390/pathogens13100829.


Electroencephalography in emerging viral infections: Lessons learned from implementing an EEG unit in a Lassa fever isolation ward in Nigeria.

Mueller H, Erameh C, Gelderblom M, Edeawe O, Akpasubi O, Ekoyata E PLoS Negl Trop Dis. 2024; 18(10):e0012522.

PMID: 39356691 PMC: 11446436. DOI: 10.1371/journal.pntd.0012522.


Discovery of Thiophene Derivatives as Potent, Orally Bioavailable, and Blood-Brain Barrier-Permeable Ebola Virus Entry Inhibitors.

Morales-Tenorio M, Lasala F, Garcia-Rubia A, Aledavood E, Heung M, Olal C J Med Chem. 2024; 67(18):16381-16402.

PMID: 39248591 PMC: 11440591. DOI: 10.1021/acs.jmedchem.4c01267.


Identification of Prospective Ebola Virus VP35 and VP40 Protein Inhibitors from Myxobacterial Natural Products.

Hayat M, Gao T, Cao Y, Rafiq M, Zhuo L, Li Y Biomolecules. 2024; 14(6).

PMID: 38927063 PMC: 11201620. DOI: 10.3390/biom14060660.


Square the Circle: Diversity of Viral Pathogens Causing Neuro-Infectious Diseases.

Nurmukanova V, Matsvay A, Gordukova M, Shipulin G Viruses. 2024; 16(5).

PMID: 38793668 PMC: 11126052. DOI: 10.3390/v16050787.


References
1.
Bwaka M, Bonnet M, Calain P, Colebunders R, de Roo A, Guimard Y . Ebola hemorrhagic fever in Kikwit, Democratic Republic of the Congo: clinical observations in 103 patients. J Infect Dis. 1999; 179 Suppl 1:S1-7. DOI: 10.1086/514308. View

2.
Brainard J, Hooper L, Pond K, Edmunds K, Hunter P . Risk factors for transmission of Ebola or Marburg virus disease: a systematic review and meta-analysis. Int J Epidemiol. 2015; 45(1):102-16. PMC: 4795563. DOI: 10.1093/ije/dyv307. View

3.
Baggi F, Taybi A, Kurth A, Van Herp M, Di Caro A, Wolfel R . Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014. Euro Surveill. 2014; 19(49). DOI: 10.2807/1560-7917.es2014.19.49.20983. View

4.
Fischer 2nd W, Uyeki T, Tauxe R . Ebola virus disease: What clinicians in the United States need to know. Am J Infect Control. 2015; 43(8):788-93. PMC: 4523406. DOI: 10.1016/j.ajic.2015.05.005. View

5.
Piercy T, Smither S, Steward J, Eastaugh L, Lever M . The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol. 2010; 109(5):1531-9. DOI: 10.1111/j.1365-2672.2010.04778.x. View